Phase 4 HIV and AIDS Trial, Recruiting (NCT06907056)

Phase 4 HIV and AIDS Trial, Recruiting NCT06907056 Sponsor: José Antonio Mata Marín Condition: HIV and AIDS

Printed from Voxsanity (voxsanity.com.au) — NCT06907056 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hiv Aids

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Men who are living with HIV and whose virus has been kept at undetectable levels for at least 6 months using a specific combination of HIV medications: darunavir/cobicistat (800mg/150mg) plus tenofovir/emtricitabine (300mg/200mg)
People aged 18 to 70 years old
People whose kidneys are functioning at a level of 30 mL/min or above, as measured by a blood test (confirm with trial site)
People who are willing to sign a written consent form agreeing to take part
People who are patients of the Mexican Social Security Institute receiving care at the Infectious Diseases Hospital of the La Raza National Medical Center in Mexico

Who may not be able to join:

People who decide to withdraw their consent to participate
People who lose their Mexican Social Security Institute medical insurance coverage during the trial
People who develop tuberculosis or another serious infection that requires a change to their HIV medication regimen
People who have incomplete information recorded during their trial visits
People with long-term gastrointestinal (digestive system) conditions that are not well controlled
People who wish to take all their HIV medications as a single combined daily pill
People who are also infected with hepatitis B virus during the trial, if they are placed in the darunavir/lamivudine treatment group (confirm with trial site)
People who are also infected with hepatitis C virus during the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 13 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06907056

Sponsor: José Antonio Mata Marín

Phase: Phase 4

Status: Recruiting

Condition: HIV and AIDS

More information: https://clinicaltrials.gov/study/NCT06907056

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Men who are living with HIV and whose virus has been kept at undetectable levels for at least 6 months using a specific combination of HIV medications: darunavir/cobicistat (800mg/150mg) plus tenofovir/emtricitabine (300mg/200mg)
People aged 18 to 70 years old
People whose kidneys are functioning at a level of 30 mL/min or above, as measured by a blood test (confirm with trial site)
People who are willing to sign a written consent form agreeing to take part
People who are patients of the Mexican Social Security Institute receiving care at the Infectious Diseases Hospital of the La Raza National Medical Center in Mexico

Who may not be able to join:

People who decide to withdraw their consent to participate
People who lose their Mexican Social Security Institute medical insurance coverage during the trial
People who develop tuberculosis or another serious infection that requires a change to their HIV medication regimen
People who have incomplete information recorded during their trial visits
People with long-term gastrointestinal (digestive system) conditions that are not well controlled
People who wish to take all their HIV medications as a single combined daily pill
People who are also infected with hepatitis B virus during the trial, if they are placed in the darunavir/lamivudine treatment group (confirm with trial site)
People who are also infected with hepatitis C virus during the trial

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 13 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

José Antonio Mata Marín

Registry

ClinicalTrials.gov

Start date

9 November 2023

Est. completion

28 February 2026

Where this trial is recruiting

🇲🇽 Mexico

Primary endpoints

Effectiveness

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov